膀胱镜与系统膀胱组织取样预测pT0膀胱癌的前瞻性试验
这项前瞻性单臂研究纳入61例接受根治性膀胱切除术的尿路上皮癌患者,评估系统内镜评估(膀胱镜+组织取样)预测pT0的可靠性。系统内镜评估阴性(seeT0)患者中51.6%存在残留病变,阴性预测值仅48.4%,试验因无效而终止。
要点
- 系统内镜评估预测pT0的阴性预测值仅48.4%,低于预设假设。
- seeT0患者中25.8%存在残留≥pT2疾病。
- 内镜评估对pT0膀胱癌的预测存在重大局限。
核心结论
- 约1/4的seeT0患者在根治性膀胱切除术时存在残留肌层浸润性膀胱癌。
- 前瞻性数据明确证实内镜评估预测pT0膀胱癌存在重大局限。
- 未来应聚焦新型影像和生物标志物策略以优化根治性膀胱切除术前的评估。
研究设计与样本
- 前瞻性单臂研究(NCT02968732),纳入接受根治性膀胱切除术的尿路上皮癌患者。
- 系统内镜评估包括膀胱镜检查和根治性膀胱切除术时的组织取样。
- 共61例患者接受系统内镜评估和根治性膀胱切除术。
- 主要终点为系统内镜评估预测根治性膀胱切除术病理的阴性预测值。
主要发现
- 系统内镜评估显示31例(50.8%)无视觉或活检疾病证据(seeT0)。
- seeT0患者中16/31(51.6%)存在残留病变(>pT0)。
- seeT0患者中8/31(25.8%)存在残留≥pT2疾病。
- 系统内镜评估预测pT0膀胱的阴性预测值为48.4%(CI 30.2-66.9),低于预设假设,试验因无效停止。
临床怎么用
- 内镜评估阴性不能可靠排除残留肌层浸润性膀胱癌。
- 对考虑保留膀胱的患者,需谨慎解读系统内镜评估结果。
局限性
- 单臂研究,样本量61例。
- 试验因无效提前终止。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Concern for discordance between clinical staging and final pathology drives current management of patients deemed appropriate candidates for radical cystectomy. Therefore, we set out to prospectively investigate reliability and shortcomings of cystoscopic evaluation in radical cystectomy candidates. MATERIALS AND METHODS: Patients undergoing radical cystectomy for urothelial carcinoma were enrolled in a prospective single-arm study to evaluate reliability of Systematic Endoscopic Evaluation in predicting pT0 urothelial carcinoma (NCT02968732). Systematic Endoscopic Evaluation consisted of cystoscopy and tissue sampling at the time of radical cystectomy. Systematic Endoscopic Evaluation results were compared to radical cystectomy pathology. The primary end point was the negative predictive value of Systematic Endoscopic Evaluation findings in predicting radical cystectomy pathology. RESULTS: A total of 61 patients underwent Systematic Endoscopic Evaluation and radical cystectomy. Indications included muscle invasive bladder cancer in 42 (68.9%) and high risk nonmuscle invasive bladder cancer in 19 (31.1%). In all, 38 (62.3%, 90.5% of patients with muscle invasive bladder cancer) received neoadjuvant chemotherapy. On Systematic Endoscopic Evaluation, 31 (50.8%) patients demonstrated no visual nor biopsy-based evidence of disease (seeT0), yet 16/31 (51.6%) harbored residual disease (>pT0), including 8 (8/31, 25.8%) with residual ≥pT2 disease upon radical cystectomy. The negative predictive value of Systematic Endoscopic Evaluation predicting a pT0 bladder was 48.4% (CI 30.2-66.9), which was below our prespecified hypothesis. Therefore, the trial was stopped for futility. CONCLUSIONS: Approximately 1 of 4 patients with seeT0 at the time of radical cystectomy harbored residual muscle invasive bladder cancer. These prospective data definitively confirm major limitations of endoscopic assessment for pT0 bladder cancer. Future work should focus on novel imaging and biomarker strategies to optimize evaluations before radical cystectomy for improved decision making regarding bladder preservation.
引用
- Zibelman M, Asghar AM, Parker DC, et al. Cystoscopy and Systematic Bladder Tissue Sampling in Predicting pT0 Bladder Cancer: A Prospective Trial. J Urol. 2021. PMID: 33535799. doi:10.1097/JU.0000000000001602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。